Stay updated on Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial
Sign up to get notified when there's something new on the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page.

Latest updates to the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new system revision tag 'Revision: v3.4.2' is displayed; the old 'Revision: v3.4.1' notice and a government funding status notice were removed, affecting only metadata and site notices rather than the study data.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a prominent notice about a lapse in government funding affecting data currency and site processing, with links to cc.nih.gov and opm.gov. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedA new 'Show glossary' option was added along with minor wording updates, including capitalization changes to QC-related labels and a new 'Revision: v3.4.0' tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page displays a new Revision: v3.3.2 label, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

Stay in the know with updates to Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page.